b3921cfb0740b499…
StudyID:
NCT00065169742 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline. |
| completionDate | 2005-11 |
| conditions | ["Alzheimer Disease","Dementia"] |
| enrollmentCount | 138 |
| enrollmentType | null |
| nctId | NCT00065169 |
| phase | NA |
| sponsorId | university-of-california-los-angeles |
| startDate | 2000-11 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | Anti-Inflammation in AD: PET Imaging Supplement |
| url | https://clinicaltrials.gov/study/NCT00065169 |
Canonical JSON
{
"id": "NCT00065169",
"type": "Study",
"data": {
"briefSummary": "The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.",
"completionDate": "2005-11",
"conditions": [
"Alzheimer Disease",
"Dementia"
],
"enrollmentCount": 138,
"enrollmentType": null,
"nctId": "NCT00065169",
"phase": "NA",
"sponsorId": "university-of-california-los-angeles",
"startDate": "2000-11",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Anti-Inflammation in AD: PET Imaging Supplement",
"url": "https://clinicaltrials.gov/study/NCT00065169"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:b3921cfb0740b499cd5ee436210b6f6c112a3ae2f16a3968ad28cd97eb0c6a00